| positive regulation of t cell mediated cytotoxicity | GO:0001916 | 15 | 0.753 | |
| regulation of tolerance induction dependent upon immune response | GO:0002652 | 1 | 0.701 | |
| regulation of leukocyte mediated cytotoxicity | GO:0001910 | 38 | 0.640 | |
| t cell activation | GO:0042110 | 289 | 0.447 | |
| negative regulation of natural killer cell mediated immunity | GO:0002716 | 5 | 0.427 | |
| positive regulation of leukocyte mediated cytotoxicity | GO:0001912 | 31 | 0.413 | |
| regulation of defense response | GO:0031347 | 233 | 0.377 | |
| innate immune response | GO:0045087 | 157 | 0.350 | |
| immune effector process | GO:0002252 | 321 | 0.319 | |
| regulation of cell killing | GO:0031341 | 40 | 0.314 | |
| regulation of t cell mediated cytotoxicity | GO:0001914 | 18 | 0.269 | |
| regulation of natural killer cell mediated immunity | GO:0002715 | 19 | 0.268 | |
| defense response to other organism | GO:0098542 | 197 | 0.255 | |
| antigen processing and presentation | GO:0019882 | 47 | 0.244 | |
| antigen processing and presentation via mhc class ib | GO:0002475 | 8 | 0.238 | |
| iron ion import into cell | GO:0097459 | 4 | 0.220 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.218 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway | GO:0002484 | 3 | 0.207 | |
| natural killer cell mediated cytotoxicity | GO:0042267 | 29 | 0.194 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class i | GO:0019885 | 3 | 0.190 | |
| regulation of natural killer cell mediated cytotoxicity | GO:0042269 | 19 | 0.181 | |
| cytokine production | GO:0001816 | 319 | 0.178 | |
| natural killer cell mediated immunity | GO:0002228 | 29 | 0.171 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib | GO:0002476 | 4 | 0.170 | |
| antigen processing and presentation of exogenous peptide antigen | GO:0002478 | 21 | 0.159 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.148 | |
| defense response to virus | GO:0051607 | 68 | 0.147 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.138 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.137 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 62 | 0.136 | |
| adaptive immune response | GO:0002250 | 155 | 0.130 | |
| cell killing | GO:0001906 | 67 | 0.129 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.126 | |
| response to protozoan | GO:0001562 | 28 | 0.119 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.115 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.114 | |
| antigen processing and presentation of peptide antigen | GO:0048002 | 29 | 0.110 | |
| regulation of lymphocyte mediated immunity | GO:0002706 | 84 | 0.103 | |
| antigen processing and presentation of exogenous antigen | GO:0019884 | 26 | 0.102 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.101 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.101 | |
| antigen processing and presentation of peptide antigen via mhc class i | GO:0002474 | 9 | 0.097 | |
| transition metal ion transport | GO:0000041 | 38 | 0.094 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.089 | |
| response to interferon gamma | GO:0034341 | 34 | 0.088 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.088 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.084 | |
| positive regulation of leukocyte mediated immunity | GO:0002705 | 70 | 0.082 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.081 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.080 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.078 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.077 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.077 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.077 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.077 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.074 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.074 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.073 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.072 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.071 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.071 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.070 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.069 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.069 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.069 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.069 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.067 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.067 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.067 | |
| positive regulation of interferon gamma production | GO:0032729 | 39 | 0.067 | |
| intracellular protein transport | GO:0006886 | 204 | 0.066 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.065 | |
| regulation of t cell mediated immunity | GO:0002709 | 34 | 0.065 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.065 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.063 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.063 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.063 | |
| gtp metabolic process | GO:0046039 | 144 | 0.062 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.062 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.061 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.061 | |
| ear development | GO:0043583 | 200 | 0.059 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.059 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.057 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.057 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.057 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.057 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.056 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.056 | |
| iron ion import | GO:0097286 | 5 | 0.056 | |
| amine metabolic process | GO:0009308 | 45 | 0.056 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.055 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.055 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.055 | |
| positive regulation of tolerance induction dependent upon immune response | GO:0002654 | 1 | 0.055 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.054 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.053 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.052 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.052 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.052 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.052 | |
| negative regulation of innate immune response | GO:0045824 | 17 | 0.052 | |
| positive regulation of cell killing | GO:0031343 | 33 | 0.052 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.051 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.051 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.051 | |
| cation transport | GO:0006812 | 399 | 0.050 | |
| antigen processing and presentation of peptide antigen via mhc class ib | GO:0002428 | 5 | 0.049 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.049 | |
| defense response to bacterium | GO:0042742 | 119 | 0.048 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.048 | |
| interferon gamma production | GO:0032609 | 67 | 0.048 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.047 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.047 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.047 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.046 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.046 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.045 | |
| t cell mediated cytotoxicity | GO:0001913 | 26 | 0.044 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.044 | |
| regulation of defense response to fungus | GO:1900150 | 1 | 0.044 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.044 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.044 | |
| cellular response to lipid | GO:0071396 | 145 | 0.044 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.043 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.043 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.042 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.042 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.042 | |
| positive regulation of natural killer cell mediated cytotoxicity | GO:0045954 | 16 | 0.041 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.041 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.041 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.041 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.039 | |
| positive regulation of t cell mediated immunity | GO:0002711 | 24 | 0.039 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.039 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.039 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.039 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.038 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.038 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.038 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.038 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.038 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.037 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.036 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.036 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.035 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.035 | |
| defense response to protozoan | GO:0042832 | 25 | 0.035 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.035 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.035 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.034 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.034 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.033 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway | GO:0002488 | 2 | 0.032 | |
| myotube differentiation | GO:0014902 | 105 | 0.032 | |
| iron ion homeostasis | GO:0055072 | 36 | 0.032 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.032 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.032 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.031 | |
| inflammatory response | GO:0006954 | 244 | 0.031 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.031 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.031 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.031 | |
| endocytosis | GO:0006897 | 168 | 0.030 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.029 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.029 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.029 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.029 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.029 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.028 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.028 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.028 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.028 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.028 | |
| antigen processing and presentation of endogenous peptide antigen | GO:0002483 | 6 | 0.028 | |
| regulation of myd88 dependent toll like receptor signaling pathway | GO:0034124 | 2 | 0.028 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.027 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.027 | |
| tolerance induction dependent upon immune response | GO:0002461 | 1 | 0.027 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.027 | |
| hormone metabolic process | GO:0042445 | 86 | 0.027 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.027 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.027 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.026 | |
| interleukin 1 production | GO:0032612 | 31 | 0.026 | |
| t cell differentiation | GO:0030217 | 174 | 0.026 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.026 | |
| response to peptide | GO:1901652 | 136 | 0.025 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.025 | |
| gtp catabolic process | GO:0006184 | 143 | 0.025 | |
| antigen processing and presentation of exogenous peptide antigen via mhc class ib | GO:0002477 | 3 | 0.025 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.025 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.025 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.025 | |
| b cell differentiation | GO:0030183 | 78 | 0.024 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.024 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.024 | |
| rna interference | GO:0016246 | 2 | 0.024 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.024 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.024 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.024 | |
| cellular homeostasis | GO:0019725 | 240 | 0.024 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.023 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.023 | |
| muscle tissue development | GO:0060537 | 308 | 0.023 | |
| disruption by host of symbiont cells | GO:0051852 | 11 | 0.023 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.023 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.023 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.023 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.023 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.023 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.022 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.022 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.022 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.022 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.022 | |
| antigen processing and presentation of endogenous antigen | GO:0019883 | 6 | 0.021 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.021 | |
| interleukin 17 production | GO:0032620 | 11 | 0.021 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.021 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.021 | |
| maintenance of location | GO:0051235 | 89 | 0.021 | |
| muscle cell development | GO:0055001 | 133 | 0.021 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.021 | |
| protein catabolic process | GO:0030163 | 221 | 0.021 | |
| positive regulation of tolerance induction | GO:0002645 | 8 | 0.021 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.021 | |
| modification by host of symbiont morphology or physiology | GO:0051851 | 12 | 0.021 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.020 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.020 | |
| protein ubiquitination | GO:0016567 | 171 | 0.020 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.020 | |
| protein localization to organelle | GO:0033365 | 185 | 0.020 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.020 | |
| gland development | GO:0048732 | 330 | 0.020 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.019 | |
| viral transcription | GO:0019083 | 3 | 0.019 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.019 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.019 | |
| protein polymerization | GO:0051258 | 57 | 0.019 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.018 | |
| nitric oxide biosynthetic process | GO:0006809 | 25 | 0.018 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.018 | |
| negative regulation of lymphocyte mediated immunity | GO:0002707 | 21 | 0.018 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.018 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.018 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.018 | |
| organelle assembly | GO:0070925 | 177 | 0.018 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.018 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.018 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.018 | |
| regulation of t cell proliferation | GO:0042129 | 92 | 0.017 | |
| mapk cascade | GO:0000165 | 281 | 0.017 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.017 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.017 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.017 | |
| positive regulation of natural killer cell mediated immunity | GO:0002717 | 16 | 0.017 | |
| modification of morphology or physiology of other organism involved in symbiotic interaction | GO:0051817 | 16 | 0.017 | |
| myosin filament organization | GO:0031033 | 3 | 0.017 | |
| regulation of cell migration | GO:0030334 | 219 | 0.017 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.017 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.017 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.017 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.017 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.017 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.017 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.017 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.017 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.017 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.017 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.017 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.017 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.016 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.016 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.016 | |
| regulation of myoblast differentiation | GO:0045661 | 29 | 0.016 | |
| striated muscle cell development | GO:0055002 | 125 | 0.016 | |
| positive regulation of killing of cells of other organism | GO:0051712 | 3 | 0.016 | |
| positive regulation of response to cytokine stimulus | GO:0060760 | 11 | 0.016 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.016 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.016 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.016 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.016 | |
| positive regulation of t helper 1 cell differentiation | GO:0045627 | 4 | 0.016 | |
| regulation of protein ubiquitination | GO:0031396 | 52 | 0.016 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.016 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.015 | |
| neuron death | GO:0070997 | 154 | 0.015 | |
| defense response to gram negative bacterium | GO:0050829 | 28 | 0.015 | |
| negative regulation of leukocyte mediated immunity | GO:0002704 | 29 | 0.015 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.015 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.015 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.015 | |
| nitric oxide metabolic process | GO:0046209 | 25 | 0.015 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.015 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.015 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.015 | |
| regulation of ion transport | GO:0043269 | 215 | 0.015 | |
| inorganic cation import into cell | GO:0098659 | 4 | 0.015 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.015 | |
| b cell activation | GO:0042113 | 161 | 0.015 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.015 | |
| spermatogenesis | GO:0007283 | 284 | 0.015 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.015 | |
| female sex differentiation | GO:0046660 | 84 | 0.014 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.014 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.014 | |
| regulation of protein localization | GO:0032880 | 231 | 0.014 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.014 | |
| lipid localization | GO:0010876 | 126 | 0.014 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.014 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.014 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.014 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.014 | |
| positive regulation of alpha beta t cell activation | GO:0046635 | 39 | 0.014 | |
| dna metabolic process | GO:0006259 | 303 | 0.014 | |
| negative regulation of muscle cell differentiation | GO:0051148 | 33 | 0.014 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.014 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.014 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| regulation of cell activation | GO:0050865 | 289 | 0.014 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.014 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.014 | |
| interleukin 1 beta production | GO:0032611 | 30 | 0.014 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.013 | |
| myosin filament assembly | GO:0031034 | 2 | 0.013 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.013 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.013 | |
| protein targeting | GO:0006605 | 143 | 0.013 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.013 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.013 | |
| myoblast differentiation | GO:0045445 | 52 | 0.013 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.013 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.013 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.013 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.013 | |
| phagocytosis | GO:0006909 | 66 | 0.013 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.013 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.013 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.013 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.013 | |
| nuclear transport | GO:0051169 | 139 | 0.013 | |
| actin filament polymerization | GO:0030041 | 44 | 0.013 | |
| response to peptide hormone | GO:0043434 | 127 | 0.013 | |
| regulation of neuron death | GO:1901214 | 134 | 0.013 | |
| negative regulation of t cell differentiation | GO:0045581 | 23 | 0.013 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.013 | |
| muscle fiber development | GO:0048747 | 76 | 0.013 | |
| protein glycosylation | GO:0006486 | 55 | 0.013 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.012 | |
| sulfur compound metabolic process | GO:0006790 | 100 | 0.012 | |
| glycosylation | GO:0070085 | 62 | 0.012 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.012 | |
| multicellular organismal iron ion homeostasis | GO:0060586 | 8 | 0.012 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.012 | |
| t cell tolerance induction | GO:0002517 | 6 | 0.012 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.012 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.012 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.012 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.012 | |
| glucose homeostasis | GO:0042593 | 128 | 0.012 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.012 | |
| camera type eye development | GO:0043010 | 266 | 0.012 | |
| histone modification | GO:0016570 | 159 | 0.012 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.012 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.012 | |
| iron ion transport | GO:0006826 | 17 | 0.012 | |
| angiogenesis | GO:0001525 | 201 | 0.012 | |
| protein import into nucleus | GO:0006606 | 95 | 0.012 | |
| regulation of nitric oxide biosynthetic process | GO:0045428 | 18 | 0.012 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.012 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.012 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.012 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.011 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.011 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.011 | |
| male gamete generation | GO:0048232 | 285 | 0.011 | |
| nuclear import | GO:0051170 | 95 | 0.011 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.011 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.011 | |
| interaction with symbiont | GO:0051702 | 14 | 0.011 | |
| modification of morphology or physiology of other organism | GO:0035821 | 18 | 0.011 | |
| germ cell development | GO:0007281 | 185 | 0.011 | |
| amide transport | GO:0042886 | 138 | 0.011 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.011 | |
| t helper 17 cell lineage commitment | GO:0072540 | 4 | 0.011 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.011 | |
| oxidation reduction process | GO:0055114 | 342 | 0.011 | |
| regulation of cell motility | GO:2000145 | 236 | 0.011 | |
| extracellular structure organization | GO:0043062 | 148 | 0.011 | |
| response to type i interferon | GO:0034340 | 12 | 0.011 | |
| ossification | GO:0001503 | 216 | 0.011 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.011 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.011 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.011 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.011 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.011 | |
| protein import | GO:0017038 | 101 | 0.011 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.011 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.011 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.011 | |
| regulation of killing of cells of other organism | GO:0051709 | 4 | 0.011 | |
| antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway tap dependent | GO:0002489 | 2 | 0.011 | |
| inositol lipid mediated signaling | GO:0048017 | 41 | 0.011 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.010 | |
| progesterone metabolic process | GO:0042448 | 4 | 0.010 | |
| microtubule based process | GO:0007017 | 236 | 0.010 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.010 | |
| dna recombination | GO:0006310 | 92 | 0.010 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.010 | |
| regulation of neutrophil mediated killing of gram negative bacterium | GO:0070951 | 1 | 0.010 | |
| positive regulation of antimicrobial humoral response | GO:0002760 | 2 | 0.010 | |
| peptide transport | GO:0015833 | 133 | 0.010 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.010 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.010 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.010 | |
| regulation of peptide secretion | GO:0002791 | 77 | 0.010 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.010 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.010 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.010 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.010 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.010 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.010 | |
| regulation of t cell anergy | GO:0002667 | 4 | 0.010 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.010 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.010 | |
| steroid metabolic process | GO:0008202 | 119 | 0.010 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.010 | |
| regulation of antimicrobial peptide production | GO:0002784 | 1 | 0.010 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.010 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.010 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.010 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.010 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.010 | |
